en · de · es · fr · pt
tirzepatide-notes.peptides9000.com › Blog › Background And Dual Receptor Pharmacology — What the Evidence Shows

Background And Dual Receptor Pharmacology — What the Evidence Shows

By Editorial Desk · published 2025-11-25 · last reviewed 2026-01-09 · Blog

If you have been reading about 稳定性 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Updated 2026-01-09. Numbers and descriptions here follow the published literature rather than marketing material.

Background and Dual Receptor Pharmacology

Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.

Receptor activation by tirzepatide raises intracellular cyclic AMP through Gs-coupled signalling at both targets. At the GLP-1 receptor the downstream effect includes glucose-dependent insulin release, suppressed glucagon secretion, delayed gastric emptying, and reduced appetite signalling in the hypothalamus. GIP receptor engagement adds insulinotropic activity and appears to influence lipid handling in adipose tissue. Because both receptors are stimulated at the same time, the pharmacological profile differs from that of selective GLP-1 receptor agonists, and the relative contribution of each arm remains an area of active investigation.

Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.

Peptide Structure and Receptor Pharmacology

Dual agonism at the GIP and GLP-1 receptors underlies the observed pharmacology. Activation of GLP-1 receptors raises glucose-dependent insulin release, lowers glucagon secretion, slows gastric emptying and reduces appetite. GIP receptor activation contributes additional effects on adipose tissue and on energy balance, and the combined action on appetite appears larger than either pathway alone in animal models. Signalling bias and the relative contribution of each receptor arm to weight-related effects remain areas of active investigation.

Structure-activity work shows that fatty acid length, linker chemistry and the position of acylation all influence albumin affinity and receptor potency. Plasma protein binding exceeds 99 percent, which restricts distribution and slows renal clearance. Degradation proceeds largely through general proteolysis and fatty acid oxidation rather than cytochrome P450 metabolism, so exposure to common oxidative drug interactions is limited. Whether these clearance routes vary meaningfully between individuals is not fully established.

The molecule is a synthetic 39-amino-acid peptide whose backbone derives from the sequence of human glucose-dependent insulinotropic polypeptide, with several substitutions that raise metabolic stability and shift receptor preference. A C20 fatty diacid is attached through a short linker to a lysine side chain, a modification that increases binding to serum albumin. The reported monoisotopic mass is approximately 4813 Da. Near neutral pH the peptide carries a net negative charge, and the lipid tail makes the molecule markedly more hydrophobic than the unmodified parent sequence.

Tirzepatide at a glance

PropertyValueNotes
Molecular formulaC225H348N48O68Unmodified peptide backbone
Molecular massapprox. 4,813 Da39-residue linear chain
Receptor targetsGIP and GLP-1Dual agonist activity
RouteSubcutaneous injectionWeekly administration interval
Elimination half-lifeapprox. 5 daysSupports weekly dosing schedule

储存处理与检测方法

质量控制环节关注外观、含量、纯度、有关物质、水分与微生物限度等项目。检测结果需要有对照品和系统适用性数据支持,单次测定不足以判定批次的稳定性。实验室之间方法转移时,色谱柱品牌与梯度差异常导致保留时间漂移,因此方法验证十分必要。

固体状态的 tirzepatide 通常以冻干粉形式保存,推荐在低温、避光、干燥条件下存放,常见区间为 2 至 8 摄氏度,长期保存可考虑更低温度并避免反复冻融。冻融循环会导致肽链聚集或析出,从而影响后续定量结果。容器密封性与湿度控制同样是稳定性研究中反复强调的因素。

溶解操作一般使用注射用水或适宜的水性缓冲液,必要时加入少量助溶剂以改善溶解速度,但应避免剧烈涡旋振荡,因为剪切力可能促进聚集。配制后的溶液在冷藏条件下的稳定时间通常短于固体形态,具体时限取决于浓度、缓冲体系与容器材质。是否加入防腐成分,则取决于用途是否为多次取样。

Related pages on this site

Storage, Stability, And Analytical Verification

Research-grade material circulates through suppliers that differ widely in documentation and testing practice, so a certificate of analysis is a starting point rather than proof of quality. Independent verification typically repeats chromatographic purity and mass confirmation on the received lot, and compares results against a retained reference standard. Regulatory status varies by jurisdiction, and a substance cleared as a medicine is not interchangeable with a research chemical of the same name. Open questions include how closely non-pharmaceutical lots match approved material in impurity profile and in aggregate content.

Solid tirzepatide is handled as a lyophilised, hygroscopic peptide powder that should be kept desiccated, protected from light, and stored frozen, typically at or below minus twenty degrees Celsius for long-term retention. Material left at ambient temperature for extended periods can take up moisture, which promotes aggregation and deamidation. Commercial liquid presentations are kept refrigerated between two and eight degrees Celsius and are not frozen. Reconstituted laboratory solutions are generally held cold and used within a short window because hydrolysis and oxidation continue slowly in solution.

Reference notes

=== Colonial and Revolutionary eras === True Asian tea (Camellia Sinensis) was first brought to North America by Dutch traders in the 17th century. In the Dutch colony of New Amsterdam, now known as New York, tea was served with the best silver strainers, the finest porcelain cups and pots, and wooden tea caddies. Regular shipments of tea to the American colonies began in the 1720s. Legally, American colonists were only supposed to buy British tea, but in reality, smuggling was widespread, and Dutch, French, and other teas were widely available. Asian tea soon became a very popular drink in the American colonies, and tea parties were common among all classes. The first tea vendors in Boston were Benjamin Harris and Daniel Vernon, who received licenses to sell tea in 1690. In Salem, Massachusetts, tea leaves were boiled to create a bitter brew, then served as a vegetable side dish with butter. By the time of the American Revolution, tea was drunk everywhere from the backwoods to the cities. The view of tea in American culture began to shift when the British government introduced the Townshend Acts in 1767. Tea was taxed as part of these laws which made it less affordable for the colonial population. However, cheaper tea was still smuggled into America. Later in 1773 the Tea Act was put into place which allowed the East India Company (EIC) to gain a monopoly on tea sales in America by being able to sell tea at prices that were cheaper than both the colonial tea importers and smugglers.

"Aleutian Islands" . Encyclopædia Britannica. Vol. I (9th ed.). 1878. pp. 479–480. U.S. Coast Pilot 9, Chapter 7, Aleutian Islands U.S. Geological Survey Geographic Names Information System: Aleutian Islands Seattle to Aleutian Island Expedition

Theft of prisoner's possessions by soldiers, dirty, cramped quarters and bad food, prisoners forced into uncomfortable positions for prolonged periods of time, extreme exposure to the elements, and excessive jailings of people based on the paid testimony of individual informants were reported. 55-year-old cafe owner Mahmoud Khodair, who was arrested and held for six months before being released in early March without ever knowing what he was charged with, stated, "It was just like hell", and "Nothing has changed since Saddam. Before, the Mukhabarat [secret police] would take us away, and at least they wouldn't blow down the door. Now, some informant fingers you and gets $100 even if you're innocent." During April 2004 the media started to report on the abuse. The journalist Seymour Hersh (who was awarded the Pulitzer Prize for his disclosure of the Vietnam War tragedy at the hamlet of My Lai) published a series of articles in The New Yorker with photo coverage of U.S. soldiers abusing prisoners in the Abu Ghraib prison on 2004-04-30. In an interview with Dan Rather, the deputy director of operations for the US-led coalition, Brig. Gen. Mark Kimmitt, stated "We're appalled. These are our fellow soldiers. These are the people we work with every day. They represent us. They wear the same uniform as us, and they let their fellow soldiers down.

== Preceding viral infections == A number of different preceding viral infections have been reported, most commonly influenza A and B. The condition appears to be more prevalent during late fall, winter, and spring. Other virus infections that have been linked to BACM are those caused by Parainfluenza, Coxsackievirus, Adenovirus, Echovirus, and Mycoplasma pneumonia. Viral myositis after viral infections may also occur in adults, and viruses, such as COVID-19, have been reported as a rare cause of myositis.

Sources: en.wikipedia.org

Notes from published material

== Gene and transcription == Obestatin is encoded by the same gene that encodes ghrelin, a peptide hormone. The mRNA produced from the GHRL gene has four exons. Five products of similar structure and function arise: the first is the 117-amino acid preproghrelin. (It is homologous to promotilin; both are members of the motilin family). It is cleaved to produce proghrelin which is cleaved to produce a 28-amino acid ghrelin (unacylated) and C-ghrelin(acylated). Obestatin is presumed to be cleaved from C-ghrelin.

=== Distribution === Ceftriaxone penetrates tissues and body fluids well, including cerebrospinal fluid to treat central nervous system infections. Ceftriaxone is reversibly bound to human plasma proteins and the binding of ceftriaxone decreases with increasing concentration from a value of 95% at plasma concentrations less than 25 mcg/mL to 85% at plasma concentration of 300 mcg/mL. Over a 0.15 to 3 g dose range in healthy adult subjects, the apparent volume of distribution ranged from 5.8 to 13.5 L.

Copper(II) salts have an LD50 of 100 mg/kg. Copper(II) sulfate was used in the past as an emetic. It is now considered too toxic for this use. It is still listed as an antidote in the World Health Organization's Anatomical Therapeutic Chemical Classification System.

http://aem.asm.org/content/79/16/5023.long He, Hongzhen; Ding, Yi; Bartlam, Mark; Sun, Fei; Le, Yi; Qin, Xincheng; Tang, Hong; Zhang, Rongguang; Joachimiak, Andrzej; Liu, Jinyuan; Zhao, Nanming; Rao, Zihe (2003). "Crystal Structure of Tabtoxin Resistance Protein Complexed with Acetyl Coenzyme A Reveals the Mechanism for β-Lactam Acetylation". Journal of Molecular Biology. 325 (5): 1019–1030. doi:10.1016/S0022-2836(02)01284-6. PMID 12527305.

He also wrote the music and the lyrics to "Hate to Feel", "Angry Chair" and "Head Creeps", and melodies to other songs. Staley's lyrics are largely viewed as having dealt with his personal troubles, such as drug use and depression. Staley also played guitar on "Angry Chair" and "Hate to Feel". Cantrell said of "Angry Chair" on the liner notes of the 1999 Music Bank box set:

Sources: en.wikipedia.org

Further detail

== Tourism == The World Economic Forum's Travel & Tourism Competitiveness Index 2017 Report, ranked Thailand 34 of 136 nations (1=most competitive, 136=least competitive). Other ASEAN nations ranked were: Singapore, 6; Malaysia, 26; Indonesia, 42; Vietnam, 67; Philippines, 79; Laos, 94; Cambodia, 101. International Tourist Arrivals and Receipts: Thailand ranked number nine in 2016, with 32.5 million arrivals. It ranked third in international tourism receipts, US$49.9 billion. Global Destinations Cities Index 2016: In this seventh annual survey published by MasterCard, Bangkok ranked number one of 100 cities worldwide as the top global destination city as determined by number of visitors. It displaced London, the previous number one. Other ASEAN cities ranked in the survey were Singapore, 6; Ho Chi Minh City, 42; Hanoi, 52; Jakarta, 66; and Manila, 74. Travel and Tourism Competitiveness Report 2015: Thailand ranked 35 of 141 nations. Among ASEAN nations, Singapore was ranked 11; Malaysia, 25: Indonesia, 50; Philippines, 74; Vietnam, 75; Laos, 96; Cambodia, 105; and Myanmar, 134. International Tourist Arrivals: Thailand ranked number ten in 2013, up five places from 2012 with 26.5 million arrivals. International Tourist Receipts: Ranked number seven in the world in 2013, up two places from 2012, with receipts estimated at US$42.1 billion. Total tourism contribution to GDP: Thailand ranked 18 of 184 nations in 2014, with travel and tourism income totalling 2,345 billion baht or 19.3 percent of GDP.

=== North America === In North America, medical physics training is offered at the master's, doctorate, post-doctorate and/or residency levels. A professional doctorate has also been recently introduced as an option. Several universities in Canada and the United States offer these degrees. As of October 2013, over 70 universities in North America have medical physics graduate programs or residencies that are accredited by The Commission on Accreditation of Medical Physics Education Programs (CAMPEP). The majority of residencies are therapy, but diagnostic and nuclear have also been on the rise in the past several years. In the United States, professional certification is obtained from the American Board of Radiology (for all 4 areas) the American Board of Medical Physics (for MRI), the American Board of Science in Nuclear Medicine (for Nuc Med and PET). As of 2012, enrollment in a CAMPEP-accredited residency or graduate program is required to start the ABR certification process. As of 2013, completion of a CAMPEP-accredited residency is required to advance to part 2 of the ABR certification process. In Canada, professional certification is obtained from the Canadian College of Physicists in Medicine (for all 4 areas and Mammography). Since 2016, eligibility requirements for Radiation Oncology Physics certification includes graduation and post-graduate training from a CAMPEP accredited institution.

Brazzein is a sweet-tasting protein that occurs naturally in oubli (Pentadiplandra brazzeana), a fruit native to the Atlantic coastal areas of Central Africa. Brazzein was named in 1994 by scientists at the University of Wisconsin–Madison. It is roughly 500 to 2000 times sweeter than sucrose. Brazzein is found in the extracellular region of oubli fruit, in the pulp tissue surrounding the seeds. It was first discovered and isolated in 1989 by Wel et al. under the name of pentadin. The corresponding author of both these publications has later opined that pentadin and brazzein are two different names for the same protein. Even though pentadin is the earlier proposed name, brazzein is the more commonly used name after more extensive characterisation of the sweet protein. Like other sweet proteins discovered in plants, such as monellin and thaumatin, brazzein is extremely sweet compared to commonly used sweeteners. The fruit tastes sweet to humans, monkeys, and bonobos, but gorillas have mutations in their sweetness receptors so that they do not find brazzein sweet, and they are not known to eat the fruit.

There is evidence that suggests that wind turbines might create sufficient barotrauma (pressure damage) to kill bats. Bats have typical mammalian lungs, which are thought to be more sensitive to sudden air pressure changes than the lungs of birds, making them more liable to fatal rupture. Bats may approach turbines to roost on them, increasing the death rate. Ultrasonic signals may help to deter bats from approaching wind farms, thus reducing deaths. The diagnosis and contribution of barotrauma to bat deaths near wind turbine blades have been disputed by other research comparing dead bats found near wind turbines with bats killed by impact with buildings in areas with no turbines. The effects of climate change on bats are debated; a 2022 literature review concluded that, "Several biological and ecological traits of bats may make them sensitive to climate change, yet there is surprisingly little evidence on how these mammals respond to this anthropogenic environmental pressure." A 2025 study of European species found that bat populations may be shifting their ranges further north. Specifically, range suitability declined markedly in southern Europe while increasing at higher northern latitudes.

== Cause == Causes may include trauma or repetitive activities. Less common causes include infection, arthritis, gout, thyroid disease, and diabetes. Obesity, or more specifically, adiposity or fatness, is linked to increasing incidence of tendinopathy. Quinolone antibiotics are associated with increased risk of tendinitis and tendon rupture. A 2013 review found the incidence of tendon injury among those taking fluoroquinolones to be between 0.08 and 0.2%. Fluoroquinolones most frequently affect large load-bearing tendons in the lower limb, especially the Achilles tendon.

Sources: en.wikipedia.org

Frequently asked questions

What class of therapeutic is tirzepatide?

It is a dual GIP and GLP-1 receptor agonist, frequently grouped with incretin-based peptide therapeutics. It is a peptide rather than a small molecule and is given by subcutaneous injection.

How does it differ from selective GLP-1 agonists?

Selective agents engage only the GLP-1 receptor, whereas tirzepatide activates GIP and GLP-1 receptors simultaneously. This difference in receptor coverage is the principal pharmacological distinction emphasised in comparative reviews.

Is the mechanism fully understood?

Downstream signalling is partly characterised, but the quantitative contribution of GIP versus GLP-1 receptor activation to metabolic outcomes is not settled. Review articles commonly flag this as an unresolved question rather than a settled finding.

Is tirzepatide a small molecule or a peptide?

It is a synthetic peptide of 39 amino acids bearing a lipid side chain. Its size and architecture place it outside the small-molecule class, and laboratories generally handle it with the precautions used for biologic-like molecules.

Network